[nomadking]

Originally Posted by Chris

Yeah ... that's not going to fly.

Section 5.4 is very clearly there to favour production inside the EU rather than outside it, and to prevent AstraZeneca producing EU vaccine outside of the EU, without first getting written permission from the EU. That clause includes the UK within the definition of the EU, purely to exempt AstraZeneca from needing EU permission to use the facilities there. The inclusion of the UK within the definition of EU is explicitly limited to section 5.4. There's nothing in 5.4 that gives the EU first call on vaccine produced in the UK.

---------- Post added at 12:47 ---------- Previous post was at 12:39 ----------

Pro tip by the way, if you're trying to search the PDF, the only mention of the UK is on one of only three pages in the document that are photocopy images rather than searchable electronic text. If I was a cynical person I might even find that a bit suspicious.

There doesn't need to be other references to UK, as the UK is included in the definition of EU manufacturing sites.

13. Representations and Warranties.
13.1. AstraZeneca. AstraZeneca represents, warrants and covenants to the
Commission and the Participating Member States that:
...(e) it is not under any obligation, contractual or otherwise, to any Person or third party in respect of the Initial Europe Doses or that conflicts with or is inconsistent
in any material respect with the terms of this Agreement or that would impede the
complete fulfillment of its obligations under this Agreement;

Hence the EU stance of

"AstraZeneca has also explicitly assured us in this contract that no other obligations would prevent the contract from being fulfilled," she said.
EU officials say AstraZeneca has been asked to send some doses manufactured in the UK to the continent to make up the shortfall, but the company said on Wednesday that its contract for UK supplies prevented this.